No products in the cart.
Rabbit Anti-TNFRSF13B Antibody (CSB-PA023971DSR2HU)
Supplier: CUSABIO BIOTECH CO.
Transmembrane activator and CAML interactor Antibody,CD267 Antibody,TNFRSF13B Antibody,TACI AntibodyMore alternative names for the antibody
CD 267 antibody|CD267 antibody|CD267 antigen antibody|CVID antibody|CVID2 antibody|FLJ39942 antibody|MGC133214 antibody|MGC39952 antibody|OTTHUMP00000065442 antibody|TNFRSF 13B antibody|TNFRSF 14B antibody|TNFRSF13B antibody|TNFRSF13B protein antibody|TNFRSF14B antibody|TR13B_HUMAN antibody|Transmembrane activator and CAML interactor antibody|Tumor necrosis factor receptor 13B antibody|Tumor necrosis factor receptor superfamily member 13B antibody
Anti-TACI antibody (ab79023)
Anti-TACI antibody (ab79023)
Recommended applications: ELISA, IHC
Recommended dilution: Recommended dilution:IHC:1:20-1:200
Recommended protocols: check protocols
|Catalogue No.|| |
Recombinant human Tumor necrosis factor receptor superfamily member 13B protein (184-293AA)
|Recommended dilution|| |
|Molecular weight|| |
Antigen Affinity Purified
Shipped at 4 Celcius Degree. Upon delivery aliquot and store at -20 Celcius Degree or -80 Celcius Degree. Avoid repeated freeze.
|Protein function|| |
Receptor for TNFSF13/APRIL and TNFSF13B/TALL1/BAFF/BLYS that binds both ligands with similar high affinity. Mediates calcineurin-dependent activation of NF-AT, as well as activation of NF-kappa-B and AP-1. Involved in the stimulation of B- and T-cell function and the regulation of humoral immunity. .
|Protein tissue specificity|| |
Highly expressed in spleen, thymus, small intestine and peripheral blood leukocytes. Expressed in resting B-cells and activated T-cells, but not in resting T-cells.
|Involvement in disease|| |
Immunodeficiency, common variable, 2 (CVID2) [MIM:240500]: A primary immunodeficiency characterized by antibody deficiency, hypogammaglobulinemia, recurrent bacterial infections and an inability to mount an antibody response to antigen. The defect results from a failure of B-cell differentiation and impaired secretion of immunoglobulins; the numbers of circulating B-cells is usually in the normal range, but can be low. . Note=The disease is caused by mutations affecting the gene represented in this entry.; Immunoglobulin A deficiency 2 (IGAD2) [MIM:609529]: Selective deficiency of immunoglobulin A (IGAD) is the most common form of primary immunodeficiency, with an incidence of approximately 1 in 600 individuals in the western world. Individuals with symptomatic IGAD often have deficiency of IgG subclasses or decreased antibody response to carbohydrate antigens such as pneumococcal polysaccharide vaccine. Individuals with IGAD also suffer from recurrent sinopulmonary and gastrointestinal infections and have an increased incidence of autoimmune disorders and of lymphoid and non-lymphoid malignancies. In vitro studies have suggested that some individuals with IGAD have impaired isotype class switching to IgA and others may have a post-switch defect. IGAD and CVID have been known to coexist in families. Some individuals initially present with IGAD1 and then develop CVID. These observations suggest that some cases of IGAD and CVID may have a common etiology. . Note=The disease is caused by mutations affecting the gene represented in this entry.
|Protein cellular localization|| |
Membrane; Single-pass type III membrane protein.
AntibodyPlus provides antibody trial sample for your own antibody validation and collects antibody reviews.
CUSABIO BIOTECH CO.
|Product type|| |
There are no reviews for this product yet.
By submitting a review, get following benefits:
1. Receive $50 ABcoins as credit for each review.
2. First trial sample order will be fully refunded as credit.
3. Have a chance to win a $50 amazon gift card!
There is no extra validation for this product yet.
Check other extra validated antibodies below: